Twist Bioscience CFO’s January 2026 Sell‑to‑Cover Sale: Market Impacts and Long‑Term Outlook
Twist Bioscience CFO sells shares to cover RSUs – does the 9% weekly rally signal a pullback? Explore insider trends, DNA platform strength, and investor outlook.
3 minutes to read